Ultraviolet spectroscopy as a tool in therapeutic protein development

Journal of Pharmaceutical Sciences

Volumn 100, Issue 4, 2011, Pages 1214-1227

  Mach, Henryk ^a   Middaugh, C Russell ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF KANSAS   (United States)

Author keywords

Physicochemical properties; Protein formulation; Protein structure; Solubility; Stability; UV spectroscopy

Indexed keywords

BEVACIZUMAB; DEUTERIUM; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; MONOCLONAL ANTIBODY; PROTEIN; TRASTUZUMAB; PROTEIN AGGREGATE;

COMPUTER; COMPUTER PROGRAM; CONCENTRATION (PARAMETERS); DATA ANALYSIS; INFORMATION; MEDICAL RESEARCH; OPTICS; PHYSICIAN; PROTEIN STRUCTURE; REVIEW; ULTRAVIOLET SPECTROSCOPY; ANIMAL; CHEMISTRY; DEVICES; HUMAN; PROCEDURES; PROTEIN STABILITY; SOLUBILITY; ULTRAVIOLET SPECTROPHOTOMETRY;

ANIMALS; ANTIBODIES, MONOCLONAL; HUMANS; PROTEIN AGGREGATES; PROTEIN STABILITY; PROTEINS; SOFTWARE; SOLUBILITY; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 79951862242     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22385     Document Type: Review

References (88)

1. Beaven GH, Holiday ER. 1952. Ultraviolet absorption spectra of proteins and amino acids: Advances in protein chemistry. Vol.7. New York: Academic Press Inc., pp 319-386.
2. Wetlaufer DB. 1962. Ultraviolet spectra of proteins and amino acids. Advan Protein Chem 17:303-390.
3. Glazer AN, Smith EL. 1961. Ultraviolet difference spectra of proteins and polypeptides. J Biol Chem 236:2942-2947.
4. Martin CJ, Bhatnagar GM. 1967. Unfolding reactions of proteins. II. Spectral and optical rotatory dispersion studies in urea, guanidinium chloride, and 2-chloroethanol. Biochemistry 6(6):1638-1650.
5. Martin CJ, Bhatnagar GM. 1966. Unfolding reactions of proteins. I. Kinetic and equilibrium measurements of diisopropylphosphorylchymotrypsin and chymotrypsinogen in urea. Biochemistry 5(4):1230-1241.
6. Eisenberg DS, Edsall JT. 1963. Spectrophotometric titrations of human serum albumin and reduced carboxy-methylated albumin. Science 142(3588):50-51.
7. Mora S, Elodi P. 1968. Near and far ultraviolet denaturation difference spectra of dehydrogenases. Eur J Biochem 5(4):574-582.
8. Donovan JW. 1969. Changes in ultraviolet absorption produced by alteration of protein conformation. J Biol Chem 244(8):1961-1967.
9. Liu P-F, Avramova LV, Park C. 2009. Revisiting absorbance at 230 nm as a protein unfolding probe. Anal Biochem 389(2):165-170.
10. Koch AL. 1961. Some calculations on the turbidity of mitochondria and bacteria. Biochim Biophys Acta 51:429-441.
11. Svedberg T, Pedersen KO. 1940. The Ultracentrifuge, Clarendon Press, Oxford, UK.
12. Laue TM. 2001. Analytical ultracentrifugation. Curr Protoc Protein Sci Chapter 7:Unit 7.5. Wiley & Sons, Hoboken, NJ.
13. Laue T. 2001. Biophysical studies by ultracentrifugation. Curr Opin Struct Biol 11(5):579-583.
14. Laue TM, Anderson AL, Demaine PD. 1994. An online interferometer for the XL-A ultracentrifuge. Prog Colloid Polym Sci 94:74-81.
15. Mitchell N. 1981. Varian Cary PLUS - a new answer to computerized UV-Vis spectrophotometry. Varian Instrum Appl 15(2):8-9.
16. Savitzky A, Golay MJE. 1964. Smoothing and differentiation of data by simplified least squares procedures. Anal Chem 36(8):1627-1639.
17. Mach H, Middaugh CR, Lewis RV. 1992. Statistical determination of the average values of the extinction coefficients of tryptophan and tyrosine in native proteins. Anal Biochem 200(1):74-80.
18. Pace CN, Vajdos F, Fee L, Grimsley G, Gray T. 1995. How to measure and predict the molar absorption coefficient of a protein. Protein Sci 4(11):2411-2423.
19. Binnig G, Gerber C, Stoll E, Albrecht TR, Quate CF. 1987. Atomic resolution with atomic force microscope. Surf Sci 189-190:1-6.
20. Mach H, Thomson JA, Middaugh CR. 1989. Quantitative analysis of protein mixtures by second derivative absorption spectroscopy. Anal Biochem 181(1):79-85.
21. Mach H, Middaugh CR. 1994. Simultaneous monitoring of the environment of tryptophan, tyrosine, and phenylalanine residues in proteins by near-ultraviolet second-derivative spectroscopy. Anal Biochem 222(2):323-331.
22. Dong A, Caughey B, Caughey WS, Bhat KS, Coe JE. 1992. Secondary structure of the pentraxin female protein in water determined by infrared spectroscopy: effects of calcium and phosphorylcholine. Biochemistry 31(39):9364-9370.
23. Kendrick BS, Dong A, Allison SD, Manning MC, Carpenter JF. 1996. Quantitation of the area of overlap between second-derivative amide I infrared spectra to determine the structural similarity of a protein in different states. J Pharm Sci 85(2):155-158.
24. Kueltzo LA, Middaugh CR. 2005. Ultraviolet absorption spectroscopy. Biotechnol Pharm Aspects 3 (Methods for structural analysis of protein pharmaceuticals):1-25.
25. Waters C. 1997. Dual wavelength absorbance detector. In Waters performance perspectives. Milford, Massachusetts: Waters Corp.
26. Mie G. 1908. Contributions to the optics of turbid media, especially colloidal metal solutions. Ann Phys 25:377-445.
27. Oreskes I, Mandel D. 1979. Spectrophotometric assay with turbidity correction of sized immunoglobulin G aggregates. Anal Biochem 99(2):346-351.
28. Winder AF, Gent WLG. 1971. Correction of light-scattering errors in spectrophotometric protein determinations. Biopolymers 10(7):1243-1251.
29. Edelhoch H. 1967. Spectroscopic determination of tryptophan and tyrosine in proteins. Biochemistry 6(7):1948-1954.
30. Mach H, Sanyal G, Volkin DB, Middaugh CR. 1997. Applications of ultraviolet absorption spectroscopy to the analysis of biopharmaceuticals. In Therapeutic protein and peptide formulation and delivery; Shahrokh Z, Sluzky V, Cleland JL, Shire SJ, Randolph TW, Eds. Washington, DC: American Chemical Society Symposium Series.
31. Fell AF, Jarvie DR, Stewart MJ. 1981. Analysis for paraquat by second- and fourth-derivative spectroscopy. Clin Chem 27(2):286-292.
32. Ichikawa T, Terada H. 1977. Second derivative spectrophotometry as an effective tool for examining phenylalanine residues in proteins. Biochim Biophys Acta 494(1):267-270.
33. O'Haver TC. 1979. Derivative and wavelength modulation spectrometry. Anal Chem 51(1):91A-92A, 94A, 96A, 99A-100A.
34. Dixit L, Ram S. 1985. Quantitative analysis by derivative electronic spectroscopy. Appl Spectrosc Rev 21(4):311-418.
35. Subert J, Farsa O. 2003. Derivative absorption spectrophotometry in the ultraviolet region as an alternative to HPLC and other instrumental methods of drug analysis. Ceska Slov Farm 52(5):218-223.
36. Stanisz B, Paszun S, Lesniak M. 2009. Validation of UV derivative spectrophotometric method for determination of benazepril hydrochloride in tablets and evaluation of its stability. Acta Pol Pharm 66(4):343-349.
37. Dias CL, Bergold AM, Froehlich PE. 2009. UV-derivative spectrophotometric determination of ritonavir capsules and comparison with LC method. Anal Lett 42(12):1900-1910.
38. Corongiu FP, Banni S, Lombardi B. 1994. Quantitation of conjugated dienes by second-derivative UV spectroscopy. Methods Toxicol 1B(In vitro toxicity indicators):415-420.
39. Bray MR, Carriere AD, Clarke AJ. 1994. Quantitation of tryptophan and tyrosine residues in proteins by fourth-derivative spectroscopy. Anal Biochem 221(2):278-284.
40. Lawrence AH, Kovar J. 1984. Analysis of heroin-morphine mixtures by zero order and second derivative ultraviolet spectrometry. Anal Chem 56(9):1731-1734.
41. Fell AF. 1978. The analysis of phenol and aromatic alcohols by second derivative UV-spectroscopy. J Pharm Pharmacol 30 (Suppl):63P.
42. Zhang J, Yan Y-B. 2005. Probing conformational changes of proteins by quantitative second-derivative infrared spectroscopy. Anal Biochem 340(1):89-98.
43. Laclair CE, Etzel MR. 2009. Turbidity and protein aggregation in whey protein beverages. J Food Sci 74(7):C526-C535.
44. Lyutova EM, Kasakov AS, Gurvits BY. 2007. Effects of arginine on kinetics of protein aggregation studied by dynamic laser light scattering and tubidimetry techniques. Biotechnol Prog 23(6):1411-1416.
45. Skrabania K, Kristen J, Laschewsky A, Akdemir O, Hoth A, Lutz J-F. 2007. Design, synthesis, and aqueous aggregation behavior of nonionic single and multiple thermoresponsive polymers. Langmuir 23(1):84-93.
46. Robitaille G, Giroux HJ, Britten M. 2004. Turbidity method to monitor the kinetics of rennet-induced coagulation of milk using a microplate reader. Milchwissenschaft Y59(9-10):479-482.
47. Wang K, Kurganov BI. 2003. Kinetics of heat- and acidification-induced aggregation of firefly luciferase. Biophys Chem 106(2):97-109.
48. Van Boekel MAJS, Nieuwenhuijse JA, Walstra P. 1989. The heat coagulation of milk. 2. Kinetic studies. Neth Milk Dairy J 43(2):129-146.
49. Hazoume RP, Hounkonnou NM. 1988. A theoretical study of the kinetics of deoxyhemoglobin S aggregation. J Chem Soc Faraday Trans 84(11):3983-3989.
50. Jamaluddin MP, Krishnan LK. 1987. A spectrophotometric method for following initial rate kinetics of blood platelet aggregation. J Biochem Biophys Methods 14(4):191-200.
51. Morris SJ, Hellweg MA, Haynes DH. 1979. Light scattering turbidity changes as a measure of the kinetics of calcium ion-promoted aggregation of chromaffin granule membrane ghosts. Biochim Biophys Acta 553(2):342-350.
52. Parker TG, Dalgleish DG. 1977. The use of light-scattering and turbidity measurements to study the kinetics of extensively aggregating proteins: as-casein. Biopolymers 16(11):2533-2547.
53. Catsimpoolas N, Funk SK, Meyer EW. 1970. Thermal aggregation of glycinin subunits. Cereal Chem 47(4):331-344.
54. European Pharmacopoeia. 2008. Clarity and degree of opalescence of liquids. 6th ed. European Directorate for the Quality of Medicine, Strasbourg, France.
55. Mahler H-C, Friess W, Grauschopf U, Kiese S. 2009. Protein aggregation: Pathways, induction factors and analysis. J Pharm Sci 98(9):2909-2934.
56. Mahler H-C, Mueller R, Friess W, Delille A, Matheus S. 2005. Induction and analysis of aggregates in a liquid IgG1-antibody formulation. Eur J Pharm Biopharm 59(3):407-417.
57. Wang W, Wang YJ, Wang DQ. 2008. Dual effects of Tween 80 on protein stability. Int J Pharm 347(1-2):31-38.
58. Cromwell MEM, Carpenter JF, Scherer T, Randolph TW. 2008. Opalescence in antibody formulations is a solution critical phenomenon. Abstracts of papers, 236th ACS National Meeting, Philadelphia, Pennsylvania: BIOT-029.
59. Ballou GA, Boyer PD, Luck JM, Lum FG. 1944. The heat coagulation of human albumin. J Biol Chem 153:589-605.
60. Nicolai T, Pouzot M, Durand D, Weijers M, Visschers RW. 2006. Iso-scattering points during heat-induced aggregation and gelation of globular proteins indicating micro-phase separation. Europhys Lett 73(2):299-305.
61. Rao G, Iyer V, Kosloski MP, Pisal DS, Shin E, Middaugh CR, Balu-Iyer SV. 2010. Use of a folding model and in situ spectroscopic techniques for rational formulation development and stability testing of monoclonal antibody therapeutics. J Pharm Sci 99(4):1697-1706.
62. Duysens LNM. 1956. Flattening of the absorption spectrum of suspensions, as compared to that of solutions. Biochim Biophys Acta 19:1-12.
63. Kim Y-S, Cape SP, Chi E, Raffen R, Wilkins-Stevens P, Stevens FJ, Manning MC, Randolph TW, Solomon A, Carpenter JF. 2001. Counteracting effects of renal solutes on amyloid fibril formation by immunoglobulin light chains. J Biol Chem 276(2):1626-1633.
64. Come JH, Fraser PE, Lansbury PT, Jr. 1993. A kinetic model for amyloid formation in the prion diseases: Importance of seeding. Proc Natl Acad Sci U S A 90(13):5959-5963.
65. Tsai PK, Volkin DB, Dabora JM, Thompson KC, Bruner MW, Gress JO, Matuszewska B, Keogan M, Bondi JV, Middaugh CR. 1993. Formulation design of acidic fibroblast growth factor. Pharm Res 10(5):649-659.
66. Kurganov BI. 2005. Protein aggregation kinetics. Chem Biol Kinet New Horiz 2:251-279.
67. Markossian KA, Golub NV, Chebotareva NA, Asryants RA, Naletova IN, Muronetz VI, Muranov KO, Kurganov BI. 2010. Comparative analysis of the effects of alpha-crystallin and GroEL on the kinetics of thermal aggregation of rabbit muscle glyceraldehyde-3-phosphate dehydrogenase. Protein J 29(1):11-25.
68. Gemmill CL. 1956. The effects of iodine on the ultraviolet absorbance spectra of thyroglobulin, casein and insulin. Arch Biochem Biophys 63(1):192-200.
69. Jiang G, Joshi SB, Peek LJ, Brandau DT, Huang J, Ferriter MS, Woodley WD, Ford BM, Mar KD, Mikszta JA, Hwang CR, Ulrich R, Harvey NG, Middaugh CR, Sullivan VJ. 2005. Anthrax vaccine powder formulations for nasal mucosal delivery. J Pharm Sci 95(1):80-96.
70. Kissman J, Ausar SF, Rudolph A, Braun C, Cape SP, Sievers RE, Federspiel MJ, Joshi SB, Middaugh CR. 2008. Stabilization of measles virus for vaccine formulation. Hum Vaccin 4(5):350-359.
71. Esfandiary R, Middaugh CR. (in print). Applications of ultraviolet spectroscopy. In Analysis of aggregates and particles in protein pharmaceuticals; Wiskoot J, Mahler H-C, Eds. Wiley and Sons, Hoboken, NJ.
72. Salinas BA, Sathish HA, Bishop SM, Harn N, Carpenter JF, Randolph TW. 2009. Understanding and modulating opalescence and viscosity in a monoclonal antibody formulation. J Pharm Sci 99(1):82-93.
73. Capelle MAH, Brugger P, Arvinte T. 2005. Spectroscopic characterization of antibodies adsorbed to aluminium adjuvants: Correlation with antibody vaccine immunogenicity. Vaccine 23(14):1686-1694.
74. Burke CJ, Steadman BL, Volkin DB, Tasi PK, Bruner MW, Middaugh CR. 1992. The adsorption of proteins to pharmaceutical container surfaces. Int J Pharm 86(1):89-93.
75. Ichikawa T, Terada H. 1979. Estimation of state and amount of phenylalanine residues in proteins by second derivative spectrophotometry. Biochim Biophys Acta 580(1):120-128.
76. Ragone R, Colonna G, Balestrieri C, Servillo L, Irace G. 1984. Determination of tyrosine exposure in proteins by second-derivative spectroscopy. Biochemistry 23(8):1871-1875.
77. Servillo L, Colonna G, Balestrieri C, Ragone R, Irace G. 1982. Simultaneous determination of tyrosine and tryptophan residues in proteins by second-derivative spectroscopy. Anal Biochem 126(2):251-257.
78. Balestrieri C, Colonna G, Giovane A, Irace G, Servillo L. 1978. Second-derivative spectroscopy of proteins. A method for the quantitative determination of aromatic amino acids in proteins. Eur J Biochem 90(3):433-440.
79. Kueltzo LA, Normand N, O'Hare P, Middaugh CR. 2000. Conformational lability of herpesvirus protein VP22. J Biol Chem 275(43):33213-33221.
80. Harn N, Spitznagel T, Perkins M, Allan C, Shire S, Middaugh CR. 2009. Biophysical signatures of monoclonal antibodies. Biotechnol: Pharm Aspects 11(Current trends in monoclonal antibody development and manufacturing):229-246.
81. Boyce W, DiPrima R. 1997. Elementary differential equations. New York: Wiley and Sons, pp 592.
82. Kueltzo LA, Middaugh CR. 2003. Structural characterization of bovine granulocyte colony stimulating factor: Effect of temperature and pH. J Pharm Sci 92(9):1793-1804.
83. Kasraian K, Kuzniar A, Earley D, Kamicker BJ, Wilson G, Manion T, Hong J, Reiber C, Canning P. 2001. Sustained in vivo activity of recombinant bovine granulocyte colony stimulating factor (rbG-CSF) using HEPES buffer. Pharm Dev Technol 6(3):441-447.
84. Herman AC, Boone TC, Lu HS. 1996. Characterization, formulation, and stability of Neupogen (Filgrastim), a recombinant human granulocyte-colony stimulating factor. Pharm Biotechnol 9:303-328.
85. Dougherty DA. 1996. Cation-pi interactions in chemistry and biology: a new view of benzene, Phe, Tyr, and Trp. Science 271(5246):163-168.
86. Gallivan JP, Dougherty DA. 1999. Cation-pi interactions in structural biology. Proc Natl Acad Sci U S A 96(17):9459-9464.
87. Esfandiary R, Hunjan JS, Lushington GH, Joshi SB, Middaugh CR. 2009. Temperature dependent 2nd derivative absorbance spectroscopy of aromatic amino acids as a probe of protein dynamics. Protein Sci 18(12):2603-2614.
88. Lucas LH, Ersoy BA, Kueltzo LA, Joshi SB, Brandau DT, Thyagarajapuram N, Peek LJ, Middaugh CR. 2006. Probing protein structure and dynamics by second-derivative ultraviolet absorption analysis of cation-pi interactions. Protein Sci 15(10):2228-2243.